{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:32:56Z","timestamp":1790649176359,"version":"4.1.0"},"reference-count":42,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2018.0091","type":"journal-article","created":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T09:36:33Z","timestamp":1517564193000},"source":"Crossref","is-referenced-by-count":22,"title":["Hereditary Neuropathies"],"prefix":"10.3238","author":[{"given":"Katja","family":"Eggermann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burkhard","family":"Gess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"H\u00e4usler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Weis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingo","family":"Kurth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2018,2,9]]},"reference":[{"key":"10.3238\/arztebl.2018.0091_ref1","doi-asserted-by":"crossref","unstructured":"Fridman V, Bundy B, Reilly MM, et al.: CMT subtypes and disease burden in patients enrolled in the inherited neuropathies consortium natural history study: a cross-sectional analysis. J Neurol Neurosurg Psychiatry 2015; 86: 873\u20138","DOI":"10.1136\/jnnp-2014-308826"},{"key":"10.3238\/arztebl.2018.0091_ref2","doi-asserted-by":"crossref","unstructured":"Baets J, De Jonghe P, Timmerman V: Recent advances in Charcot-Marie-Tooth disease. Curr Opin Neurol 2014; 27: 532\u201340","DOI":"10.1097\/WCO.0000000000000131"},{"key":"10.3238\/arztebl.2018.0091_ref3","doi-asserted-by":"crossref","unstructured":"Timmerman V, Strickland AV, Zuchner S: Genetics of Charcot-Marie-Tooth (CMT) disease within the frame of the human genome project success. Genes (Basel) 2014; 5: 13\u201332","DOI":"10.3390\/genes5010013"},{"key":"10.3238\/arztebl.2018.0091_ref4","doi-asserted-by":"crossref","unstructured":"Werheid F, Azzedine H, Zwerenz E, et al.: Underestimated associated features in CMT neuropathies: clinical indicators for the causative gene? Brain Behav 2016; 6: e00451","DOI":"10.1002\/brb3.451"},{"key":"10.3238\/arztebl.2018.0091_ref5","doi-asserted-by":"crossref","unstructured":"Rotthier A, Baets J, Timmerman V, Janssens K: Mechanisms of disease in hereditary sensory and autonomic neuropathies. Nat Rev Neurol 2012; 8: 73\u201385","DOI":"10.1038\/nrneurol.2011.227"},{"key":"10.3238\/arztebl.2018.0091_ref6","doi-asserted-by":"crossref","unstructured":"Mellgren SI, Nolano M, Sommer C: The cutaneous nerve biopsy: technical aspects, indications, and contribution. Handb Clin Neurol 2013; 115: 171\u201388","DOI":"10.1016\/B978-0-444-52902-2.00010-2"},{"key":"10.3238\/arztebl.2018.0091_ref7","unstructured":"Dyck PJ, Thomas PK (eds.): Peripheral neuropathy. 4th ed. Philadelphia: Saunders 2005."},{"key":"10.3238\/arztebl.2018.0091_ref8","doi-asserted-by":"crossref","unstructured":"Grimm A, Vittore D, Schubert V, et al.: Ultrasound pattern sum score, homogeneity score and regional nerve enlargement index for differentiation of demyelinating inflammatory and hereditary neuropathies. Clin Neurophysiol 2016; 127: 2618\u201324","DOI":"10.1016\/j.clinph.2016.04.009"},{"key":"10.3238\/arztebl.2018.0091_ref9","doi-asserted-by":"crossref","unstructured":"Loewenbruck KF, Dittrich M, Bohm J, et al.: Diagnostic accuracy of nerve ultrasound in hereditary and sporadic non-entrapment neuropathies. J Neurol 2016; 263: 2196\u2013206","DOI":"10.1007\/s00415-016-8242-9"},{"key":"10.3238\/arztebl.2018.0091_ref10","doi-asserted-by":"crossref","unstructured":"Morrow JM, Sinclair CD, Fischmann A, et al.: MRI biomarker assessment of neuromuscular disease progression: a prospective observational cohort study. Lancet Neurol 2016; 15: 65\u201377","DOI":"10.1016\/S1474-4422(15)00242-2"},{"key":"10.3238\/arztebl.2018.0091_ref11","doi-asserted-by":"crossref","unstructured":"Sommer CL, Brandner S, Dyck PJ, et al.: Peripheral Nerve Society guideline on processing and evaluation of nerve biopsies. J Peripher Nerv Syst 2010; 15: 164\u201375","DOI":"10.1111\/j.1529-8027.2010.00276.x"},{"key":"10.3238\/arztebl.2018.0091_ref12","doi-asserted-by":"crossref","unstructured":"Weis J, Brandner S, Lammens M, Sommer C, Vallat JM: Processing of nerve biopsies: a practical guide for neuropathologists. Clin Neuropathol 2012; 31: 7\u201323","DOI":"10.5414\/NP300468"},{"key":"10.3238\/arztebl.2018.0091_ref13","doi-asserted-by":"crossref","unstructured":"Baets J, Deconinck T, De Vriendt E, et al.: Genetic spectrum of hereditary neuropathies with onset in the first year of life. Brain 2011; 134: 2664\u201376","DOI":"10.1093\/brain\/awr184"},{"key":"10.3238\/arztebl.2018.0091_ref14","doi-asserted-by":"crossref","unstructured":"Tazir M, Bellatache M, Nouioua S, Vallat JM: Autosomal recessive Charcot-Marie-Tooth disease: from genes to phenotypes. J Peripher Nerv Syst 2013; 18: 113\u201329","DOI":"10.1111\/jns5.12026"},{"key":"10.3238\/arztebl.2018.0091_ref15","doi-asserted-by":"crossref","unstructured":"Saporta AS, Sottile SL, Miller LJ, Feely SM, Siskind CE, Shy ME: Charcot-Marie-Tooth disease subtypes and genetic testing strategies. Ann Neurol 2011; 69: 22\u201333","DOI":"10.1002\/ana.22166"},{"key":"10.3238\/arztebl.2018.0091_ref16","doi-asserted-by":"crossref","unstructured":"Rudnik-Schoneborn S, Tolle D, Senderek J, et al.: Diagnostic algorithms in Charcot-Marie-Tooth neuropathies: experiences from a German genetic laboratory on the basis of 1206 index patients. Clin Genet 2016; 89: 34\u201343","DOI":"10.1111\/cge.12594"},{"key":"10.3238\/arztebl.2018.0091_ref17","doi-asserted-by":"crossref","unstructured":"Tomaselli PJ, Rossor AM, Horga A, et al.: Mutations in noncoding regions of GJB1 are a major cause of X-linked CMT. Neurology 2017; 88: 1445\u201353","DOI":"10.1212\/WNL.0000000000003819"},{"key":"10.3238\/arztebl.2018.0091_ref18","doi-asserted-by":"crossref","unstructured":"Hoeijmakers JG, Faber CG, Lauria G, Merkies IS, Waxman SG: Small-fibre neuropathies\u2014advances in diagnosis, pathophysiology and management. Nat Rev Neurol 2012; 8: 369\u201379","DOI":"10.1038\/nrneurol.2012.97"},{"key":"10.3238\/arztebl.2018.0091_ref19","doi-asserted-by":"crossref","unstructured":"Kurth I: [Sensory and autonomic neuropathies and pain-related channelopathies]. Schmerz 2015; 29: 445\u201357","DOI":"10.1007\/s00482-015-0024-2"},{"key":"10.3238\/arztebl.2018.0091_ref20","doi-asserted-by":"crossref","unstructured":"Bansagi B, Griffin H, Whittaker RG, et al.: Genetic heterogeneity of motor neuropathies. Neurology 2017; 88: 1226\u201334","DOI":"10.1212\/WNL.0000000000003772"},{"key":"10.3238\/arztebl.2018.0091_ref21","doi-asserted-by":"crossref","unstructured":"Rudnik-Schoneborn S, Auer-Grumbach M, Senderek J: Hereditary neuropathies: update 2017. Neuropediatrics 2017; 48: 282\u20139","DOI":"10.1055\/s-0037-1603518"},{"key":"10.3238\/arztebl.2018.0091_ref22","doi-asserted-by":"crossref","unstructured":"Rossor AM, Polke JM, Houlden H, Reilly MM: Clinical implications of genetic advances in Charcot-Marie-Tooth disease. Nat Rev Neurol 2013; 9: 562\u201371","DOI":"10.1038\/nrneurol.2013.179"},{"key":"10.3238\/arztebl.2018.0091_ref23","doi-asserted-by":"crossref","unstructured":"Wang W, Wang C, Dawson DB, et al.: Target-enrichment sequencing and copy number evaluation in inherited polyneuropathy. Neurology 2016; 86: 1762\u201371","DOI":"10.1212\/WNL.0000000000002659"},{"key":"10.3238\/arztebl.2018.0091_ref24","doi-asserted-by":"crossref","unstructured":"Antoniadi T, Buxton C, Dennis G, et al.: Application of targeted multi-gene panel testing for the diagnosis of inherited peripheral neuropathy provides a high diagnostic yield with unexpected phenotype-genotype variability. BMC Med Genet 2015; 16: 84","DOI":"10.1186\/s12881-015-0224-8"},{"key":"10.3238\/arztebl.2018.0091_ref25","doi-asserted-by":"crossref","unstructured":"Gess B, Schirmacher A, Boentert M, Young P: Charcot-Marie-Tooth disease: frequency of genetic subtypes in a German neuromuscular center population. Neuromuscul Disord 2013; 23: 647\u201351","DOI":"10.1016\/j.nmd.2013.05.005"},{"key":"10.3238\/arztebl.2018.0091_ref26","unstructured":"Bird TD: Charcot-Marie-Tooth neuropathy type 4. In: Pagon RA, Adam MP, Ardinger HH, et al. (eds.): GeneReviews. Seattle (WA) 1993."},{"key":"10.3238\/arztebl.2018.0091_ref27","doi-asserted-by":"crossref","unstructured":"Wilmshurst JM, Ouvrier R: Hereditary peripheral neuropathies of childhood: an overview for clinicians. Neuromuscul Disord 2011; 21: 763\u201375","DOI":"10.1016\/j.nmd.2011.05.013"},{"key":"10.3238\/arztebl.2018.0091_ref28","doi-asserted-by":"crossref","unstructured":"Kalia SS, Adelman K, Bale SJ, et al.: Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. Genet Med 2017; 19: 249\u201355","DOI":"10.1038\/gim.2017.17"},{"key":"10.3238\/arztebl.2018.0091_ref29","doi-asserted-by":"crossref","unstructured":"Weis J, Claeys KG, Roos A, et al.: Towards a functional pathology of hereditary neuropathies. Acta Neuropathol 2017; 133: 493\u2013515","DOI":"10.1007\/s00401-016-1645-y"},{"key":"10.3238\/arztebl.2018.0091_ref30","doi-asserted-by":"crossref","unstructured":"Hayasaka K, Himoro M, Sato W, et al.: Charcot-Marie-Tooth neuropathy type 1B is associated with mutations of the myelin P0 gene. Nat Genet 1993; 5: 31\u20134","DOI":"10.1038\/ng0993-31"},{"key":"10.3238\/arztebl.2018.0091_ref31","doi-asserted-by":"crossref","unstructured":"Kleffner I, Schirmacher A, Gess B, Boentert M, Young P: Four novel mutations of the myelin protein zero gene presenting as a mild and late-onset polyneuropathy. J Neurol 2010; 257: 1864\u20138","DOI":"10.1007\/s00415-010-5624-2"},{"key":"10.3238\/arztebl.2018.0091_ref32","doi-asserted-by":"crossref","unstructured":"Marrosu MG, Vaccargiu S, Marrosu G, Vannelli A, Cianchetti C, Muntoni F: Charcot-Marie-Tooth disease type 2 associated with mutation of the myelin protein zero gene. Neurology 1998; 50: 1397\u2013401","DOI":"10.1212\/WNL.50.5.1397"},{"key":"10.3238\/arztebl.2018.0091_ref33","doi-asserted-by":"crossref","unstructured":"Hubner CA, Kurth I: Membrane-shaping disorders: a common pathway in axon degeneration. Brain 2014; 137: 3109\u201321","DOI":"10.1093\/brain\/awu287"},{"key":"10.3238\/arztebl.2018.0091_ref34","doi-asserted-by":"crossref","unstructured":"Timmerman V, Clowes VE, Reid E: Overlapping molecular pathological themes link Charcot-Marie-Tooth neuropathies and hereditary spastic paraplegias. Exp Neurol 2013; 246: 14\u201325","DOI":"10.1016\/j.expneurol.2012.01.010"},{"key":"10.3238\/arztebl.2018.0091_ref35","doi-asserted-by":"crossref","unstructured":"Jungbluth H, Wallgren-Pettersson C, Laporte J: Centronuclear (myotubular) myopathy. Orphanet J Rare Dis 2008; 3: 26","DOI":"10.1186\/1750-1172-3-26"},{"key":"10.3238\/arztebl.2018.0091_ref36","doi-asserted-by":"crossref","unstructured":"Chow CY, Landers JE, Bergren SK, et al.: Deleterious variants of FIG4, a phosphoinositide phosphatase, in patients with ALS. Am J Hum Genet 2009; 84: 85\u20138","DOI":"10.1016\/j.ajhg.2008.12.010"},{"key":"10.3238\/arztebl.2018.0091_ref37","doi-asserted-by":"crossref","unstructured":"Chow CY, Zhang Y, Dowling JJ, et al.: Mutation of FIG4 causes neurodegeneration in the pale tremor mouse and patients with CMT4J. Nature 2007; 448: 68\u201372","DOI":"10.1038\/nature05876"},{"key":"10.3238\/arztebl.2018.0091_ref38","doi-asserted-by":"crossref","unstructured":"Harel T, Lupski JR: Charcot-Marie-Tooth disease and pathways to molecular based therapies. Clin Genet 2014; 86: 422\u201331","DOI":"10.1111\/cge.12393"},{"key":"10.3238\/arztebl.2018.0091_ref39","doi-asserted-by":"crossref","unstructured":"Garofalo K, Penno A, Schmidt BP, et al.: Oral L-serine supplementation reduces production of neurotoxic deoxysphingolipids in mice and humans with hereditary sensory autonomic neuropathy type 1. J Clin Invest 2011; 121: 4735\u201345","DOI":"10.1172\/JCI57549"},{"key":"10.3238\/arztebl.2018.0091_ref40","doi-asserted-by":"crossref","unstructured":"Gonzaga-Jauregui C, Harel T, Gambin T, et al.: Exome sequence analysis suggests that genetic burden contributes to phenotypic variability and complex neuropathy. Cell Rep 2015; 12: 1169\u201383","DOI":"10.1016\/j.celrep.2015.07.023"},{"key":"10.3238\/arztebl.2018.0091_ref41","doi-asserted-by":"crossref","unstructured":"Sommer C, Geber C, Young P, Forst R, Birklein F, Schoser B: Polyneuropathies\u2014etiology, diagnosis, and treatment options. Dtsch Arztebl Int 2018; 115: 83\u201390.","DOI":"10.3238\/arztebl.2018.0083"},{"key":"10.3238\/arztebl.2018.0091_ref42","unstructured":"Deutsche Gesellschaft f\u00fcr Humangenetik: Stellungnahme der Deutschen Gesellschaft f\u00fcr Humangenetik zu genetischen Zusatzbefunden in Diagnostik und Forschung. 2013. www.gfhev.de\/de\/leitlinien\/LL_und_Stellungnahmen\/2013_05_28_Stellungnahme_zu_genetischen_Zufallsbefunden.pdf (last accessed on 1 December 2017)."}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2018.0091","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T13:18:15Z","timestamp":1638796695000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2018.0091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,9]]},"references-count":42,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2018.0091","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,9]]}}}